Each case study showcases how we deliver impactful, tailored solutions.
Restoring Momentum: Restarting a Global First-in-Human Pneumonia Study
Micron rescued a suspended 29-site FIH pneumonia trial, restarting operations and completing enrolment on schedule.
Rapid Initiation and Agile Delivery: Phase I COVID-19 Vaccine Trial
This successful trial was completed when the milestone of database lock was achieved just four weeks after last patient last visit.
CODAR: Linking Real-World Outcomes with Antimicrobial Resistance Data
8,060 hospitalised patient records were submitted — 7,444 (92%) were complete enough to include in the final analysis.
ATLAS: Powering Global Antimicrobial Resistance Surveillance
8+ million records across 900,000+ clinical isolates — searchable by pathogen, antimicrobial, demographics, phenotype and genotype.